Clinical trial
Genomic Study of Relapse Esophageal Cancer After Radiotherapy
NCT04694391 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genomic Study of Relapse Esophageal Cancer After Radiotherapy
- Lead sponsor
- Fudan University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 14, 2012
- Completion date
- December 31, 2022
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal cancer, gene mutation-related cancer, radiation exposure